CHERISH HOLT: Open Payments
NPI 1659703817 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,417 in 136 payments from 27 companies in 2025. Trend: 2023 $4,550 · 2024 $4,079 · 2025 $3,417
Food & beverage: $3,375Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $448 |
| CeQur Corporation | 1 | $403 |
| Lilly USA, LLC | 20 | $401 |
| BETA BIONICS, INC. | 10 | $328 |
| Abbott Laboratories | 15 | $321 |
| Amgen Inc. | 14 | $241 |
| Xeris Pharmaceuticals, Inc. | 11 | $238 |
| Sequel Med Tech, LLC | 4 | $184 |
| Medtronic, Inc. | 4 | $105 |
| Mannkind Corporation | 3 | $100 |
Products named: CeQur Simplicity, iLet Bionic Pancreas, FREESTYLE LIBRE 3, MOUNJARO, Ozempic, GVOKE HYPOPEN, Wegovy, TWIIST.
Industry payments across TN — which companies pay providers there.
